OnKure Therapeutics (OKUR) Non-Current Assets (2020 - 2026)

OnKure Therapeutics (OKUR) has reported Non-Current Assets for 7 consecutive years, with $1.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non-Current Assets rose 10.41% year-over-year to $1.7 million; the trailing twelve-month figure through Jun 2026 stood at $5.5 million (down 5.24% YoY), and the FY2025 full-year result was $1.3 million, down 32.88% from the prior year.
• Non-Current Assets rose to $1.7 million in Q2 2026 per OKUR's latest filing, from $1.2 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $2.0 million in Q4 2023 and bottomed at $646000.0 in Q3 2024.
• Historically, Non-Current Assets has averaged $1.5 million across 5 years, with a median of $1.6 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Non-Current Assets surged 879.75% in 2022, then tumbled 61.51% in 2024.
• Over 5 years, Non-Current Assets stood at $1.8 million in 2022, then grew by 7.6% to $2.0 million in 2023, then fell by 3.25% to $1.9 million in 2024, then slumped by 32.88% to $1.3 million in 2025, then jumped by 31.14% to $1.7 million in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $1.7 million, $1.2 million, and $1.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.